NCT06095167View on ClinicalTrials.gov

Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

476

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2028

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

without concurrent cisplatin chemotherapy

IMRT without concurrent cisplatin chemotherapy

DRUG

with concurrent cisplatin chemotherapy

IMRT with concurrent cisplatin chemotherapy

Trial Locations (1)

350014

Department of radiation oncology, Fujian cancer hospital, Fuzhou

All Listed Sponsors
lead

Fujian Cancer Hospital

OTHER_GOV